Literature DB >> 10193519

Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.

P M De Angelis1, T Stokke, L Thorstensen, R A Lothe, O P Clausen.   

Abstract

AIMS: Spontaneous apoptosis and expression of the apoptotic regulatory proteins Bax, Bcl-x, and Bcl-2 were investigated in 50 colorectal carcinomas. The p53 genotypes/phenotypes and BAX genotypes were also determined, and possible associations of these with apoptosis and/or with expression of the different apoptotic regulatory proteins were studied.
METHODS: Terminal deoxynucleotidyl transferase (TdT) mediated dUTP labelling of DNA fragments was used to detect apoptotic tumour cells in sections and peroxidase immunohistochemistry was used to assess protein expression. p53 genotype/phenotype was determined using constant denaturant gel electrophoresis/immunoblotting and bax genotype was determined using polymerase chain reaction based methods.
RESULTS: The distribution of tumour apoptotic indices was bimodal with a natural cut off at 1.0% (range, 0.0-5.4%); the median fraction of apoptotic tumour cells was 0.8%. Tumour apoptosis was not associated significantly with tumour DNA ploidy status. Normal mucosal tissue had less than 0.1% apoptotic cells. Staining intensities for Bax, Bcl-x, and Bcl-2 were strong; that is, equivalent to or greater than positive normal mucosal cells, in 11 of 50, 20 of 49, and 20 of 48 carcinomas. Frameshift mutations in the bax gene were detected in three of 42 tumours analysed, all of which were DNA diploid, and Bax protein expression in these tumours was absent or very low. Bax, Bcl-x, and Bcl-2 protein expression were not correlated with tumour apoptosis or tumour DNA ploidy status. p53 was expressed in 34 of 50 tumours and p53 gene mutations were detected in 22 of 29 p53 positive tumours analysed. Apoptosis was significantly lower in a greater number of p53 positive tumours than p53 negative tumours. In addition, Bcl-2 protein expression was significantly higher in a greater number of p53 positive tumours compared with p53 negative tumours. Bax and Bcl-x protein expression were not significantly associated with p53 phenotype/genotype.
CONCLUSIONS: The results indicate that acquisition of a p53 phenotype is associated with lower spontaneous apoptosis and higher expression of Bcl-2. The results also suggest that p53 is not a major determinant for Bax expression in colorectal carcinomas in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10193519      PMCID: PMC395648          DOI: 10.1136/mp.51.5.254

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  35 in total

Review 1.  Molecular thanatopsis: a discourse on the BCL2 family and cell death.

Authors:  E Yang; S J Korsmeyer
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

Review 2.  The proto-oncogene Bcl-2 and its role in regulating apoptosis.

Authors:  G Kroemer
Journal:  Nat Med       Date:  1997-06       Impact factor: 53.440

3.  Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.

Authors:  M Krajewska; S F Moss; S Krajewski; K Song; P R Holt; J C Reed
Journal:  Cancer Res       Date:  1996-05-15       Impact factor: 12.701

4.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

5.  Down-regulation of bcl-2 by p53 in breast cancer cells.

Authors:  S Haldar; M Negrini; M Monne; S Sabbioni; C M Croce
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

6.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.

Authors:  T Ried; R Knutzen; R Steinbeck; H Blegen; E Schröck; K Heselmeyer; S du Manoir; G Auer
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

7.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

8.  Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection.

Authors:  E Hovig; B Smith-Sørensen; A Brøgger; A L Børresen
Journal:  Mutat Res       Date:  1991-01       Impact factor: 2.433

9.  Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2.

Authors:  S Krajewski; M Krajewska; A Shabaik; T Miyashita; H G Wang; J C Reed
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

10.  Allelic loss of chromosome 18q and prognosis in colorectal cancer.

Authors:  J Jen; H Kim; S Piantadosi; Z F Liu; R C Levitt; P Sistonen; K W Kinzler; B Vogelstein; S R Hamilton
Journal:  N Engl J Med       Date:  1994-07-28       Impact factor: 91.245

View more
  13 in total

1.  Bax expression is a candidate prognostic and predictive marker of colorectal cancer.

Authors:  Venkat R Katkoori; Catalina Suarez-Cuervo; Chandrakumar Shanmugam; Nirag C Jhala; Tom Callens; Ludwine Messiaen; James Posey; Harvey L Bumpers; Sreelatha Meleth; William E Grizzle; Upender Manne
Journal:  J Gastrointest Oncol       Date:  2010-12

2.  Antioxidant dietary supplementation in mice exposed to proton radiation attenuates expression of programmed cell death-associated genes.

Authors:  J K Sanzari; C Wambi; J S Lewis-Wambi; A R Kennedy
Journal:  Radiat Res       Date:  2011-03-28       Impact factor: 2.841

3.  Prodigiosin isolated from cell wall of Serratia marcescens alters expression of apoptosis-related genes and increases apoptosis in colorectal cancer cells.

Authors:  Ramin Hassankhani; Mohammad Reza Sam; Mohammad Esmaeilou; Prinaz Ahangar
Journal:  Med Oncol       Date:  2014-11-28       Impact factor: 3.064

4.  Correlation study of Bcl-2, B7-H1, EGFR, VEGF and colorectal cancer.

Authors:  Xiao-Feng Li; Xian-Feng Liu; Yong-Yan Yang; Ai-Yong Liu; Mei-Yun Zhang; Xue-Feng Bai; Hui Gao; Xiao-Guang Guo
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

5.  MIB-1, Bcl-2 and p53 in odontogenic myxomas of the jaws.

Authors:  G Iezzi; A Piattelli; C Rubini; L Artese; M Fioroni; F Carinci
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-10       Impact factor: 2.124

6.  Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer.

Authors:  A Paradiso; G Simone; M D Lena; B Leone; C Vallejo; J Lacava; S Dellapasqua; M G Daidone; A Costa
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

7.  An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.

Authors:  S Cascinu; F Graziano; V Catalano; M P Staccioli; M C Rossi; A M Baldelli; S Barni; A Brenna; S Secondino; P Muretto; G Catalano
Journal:  Br J Cancer       Date:  2002-03-04       Impact factor: 7.640

8.  Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.

Authors:  P M De Angelis; O P Clausen; A Schjølberg; T Stokke
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

9.  The Role of p53 in Marijuana Smoke Condensates-induced Genotoxicity and Apoptosis.

Authors:  Ha Ryong Kim; Bo Hee Son; Soo Yeun Lee; Kyu Hyuck Chung; Seung Min Oh
Journal:  Environ Health Toxicol       Date:  2012-09-30

10.  Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.

Authors:  Paula M De Angelis; Katherine L Kravik; Siv H Tunheim; Terje Haug; Wenche H Reichelt
Journal:  Mol Cancer       Date:  2004-04-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.